What is Veracyte's other income (expense)?

Veracyte (VCYT) reported other income (expense) of $7.33M in Q1 2026.

How has Veracyte's other income (expense) changed year-over-year?

Veracyte's other income (expense) increased by 62.0% year-over-year, from $4.52M to $7.33M.

What is the long-term trend for Veracyte's other income (expense)?

Over 4 years (2021 to 2025), Veracyte's other income (expense) has grown at a 153.1% compound annual growth rate (CAGR), from $254K to $10.42M.

What does other income (expense) mean?

Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Veracyte VCYT Other Income (Expense)

Other Income (Expense) at other companies

Guardant HealthGH

-$157K-102%

Bio-Rad LaboratoriesBIO

$24.2M-34.9%

Labcorp HoldingsLH

-$13.1M-1,210%

Quest DiagnosticsDGX

-$65M+7.1%

Natera, Inc.NTRA

——

RevvityRVTY

——

Segments

By segment

See full

Reportable Segment$7.33M+62.0%

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.29B+10.7%

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's other income (expense)?: Veracyte (VCYT) reported other income (expense) of $7.33M in Q1 2026.
How has Veracyte's other income (expense) changed year-over-year?: Veracyte's other income (expense) increased by 62.0% year-over-year, from $4.52M to $7.33M.
What is the long-term trend for Veracyte's other income (expense)?: Over 4 years (2021 to 2025), Veracyte's other income (expense) has grown at a 153.1% compound annual growth rate (CAGR), from $254K to $10.42M.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.